Free Trial

Cronos Group (NASDAQ:CRON) Hits New 12-Month Low - What's Next?

Cronos Group logo with Medical background
Remove Ads

Cronos Group Inc. (NASDAQ:CRON - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $1.72 and last traded at $1.78, with a volume of 205587 shares traded. The stock had previously closed at $1.79.

Cronos Group Price Performance

The company has a market capitalization of $654.13 million, a P/E ratio of -13.15, a price-to-earnings-growth ratio of 1.74 and a beta of 1.02. The firm's 50-day moving average is $1.91 and its 200-day moving average is $2.02.

Institutional Trading of Cronos Group

A number of large investors have recently made changes to their positions in the business. Barclays PLC purchased a new position in shares of Cronos Group during the 3rd quarter worth about $97,000. Janney Montgomery Scott LLC boosted its position in shares of Cronos Group by 72.2% during the fourth quarter. Janney Montgomery Scott LLC now owns 380,575 shares of the company's stock valued at $769,000 after buying an additional 159,575 shares during the period. Jones Financial Companies Lllp grew its stake in shares of Cronos Group by 64.5% during the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock valued at $34,000 after buying an additional 6,520 shares during the last quarter. SBI Securities Co. Ltd. purchased a new stake in shares of Cronos Group in the fourth quarter worth approximately $30,000. Finally, WINTON GROUP Ltd lifted its stake in shares of Cronos Group by 106.5% during the 4th quarter. WINTON GROUP Ltd now owns 288,990 shares of the company's stock worth $584,000 after acquiring an additional 149,028 shares during the last quarter. 8.71% of the stock is currently owned by institutional investors.

Remove Ads

About Cronos Group

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

See Also

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads